Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone Effects on Repolarization in Hypogonadism and Heart Failure
NCT03126656Phase 4Completed
- Sponsor
- Sapienza University of Rome
- Start
- Sep 2016
- Primary completion
- Apr 2017
- Modality
- Hormone, Biologic
01
Overview
Phase 4, open-label trial of testosterone undecanoate in Hypogonadism (3 arms), sponsored by Sapienza University of Rome. Primary endpoint: QT duration reduction at 6 months. Started Sep 2016; status: completed.
02
Drugs
testosterone undecanoate
03
Conditions
Hypogonadism
Beyond the preview
Go deeper on NCT03126656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03126656.